MT Public Health Laboratory Surveillance

 

Guidance Document for Implementation of Antimicrobial Resistance Testing at MTPHL

  • CDC’s Epidemiology and Laboratory Capacity Cooperative agreement (ELC) has requested Public Health Laboratories to collect, confirm, and characterize antimicrobial resistant organisms, including carbapenem-resistant Enterobacteriaceae (CRE), Pseudomonas aeruginosa (CRPA), and Candida spp. (especially C. auris). Isolates will be collected from jurisdictional healthcare facilities using a strategy that allows for estimating the burden of antimicrobial resistance within the population served by the Public Health Laboratory. The Public Health Laboratory and state Epidemiologists will collaborate with the state HAI/AR prevention programs and with the Antimicrobial Resistance Laboratory Network regional laboratories (ARLN). This Guidance document will identify expectations for testing, submitting, and reporting. Download the complete guidance document.

Surveillance for the 2026-2027 influenza season has officially started (beginning October 4, 2026). Receiving positive influenza specimens at Montana Public Health Lab (MTPHL) for surveillance testing is essential in determining the circulating strains and prevalence. MTPHL also shares these specimens with the Centers for Disease Control for further characterization and testing for antiviral resistance.

Please give us a call at 800-821-7284.

Montana Department of Health and Human Services (DPHHS) needs your help this season to improve our outbreak surveillance regarding Norovirus in Montana. Gastroenteritis outbreaks or any outbreaks that occur in congregate settings such as schools, nursing homes and child cares are reportable and provide a glimpse inside infectious diseases in Montana. DPHHS is asking our partners to do their part to improve our understanding of norovirus in Montana. 

Letter to laboratories regarding submission of specimens for Norovirus surveillance and outbreak investigation.